| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | -100.0% | -100.0% |
| R&D Expense | $4.3M | +20.6% | +128.0% |
| SG&A Expense | $5.2M | +106.5% | +88.4% |
| Operating Income | -$9.4M | -58.7% | -113.7% |
| Income Tax | $0 | — | — |
| Net Income | -$9.0M | -57.2% | -106.1% |
| EPS (Basic) | -$0.09 | +18.2% | +81.3% |
| EPS (Diluted) | -$0.09 | +18.2% | +81.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.7M | +2.0% | +308.7% |
| Accounts Receivable | $0 | -100.0% | — |
| Current Assets | $53.4M | +5.1% | +544.2% |
| Total Assets | $64.4M | +0.4% | +196.8% |
| Current Liabilities | $5.9M | -2.4% | +25.3% |
| Total Liabilities | $7.8M | -3.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.9M | -92.5% | — |
| Capital Expenditures | $548K | +1612.5% | — |
| Investing Cash Flow | -$24.5M | -13.9% | — |
| Financing Cash Flow | $55.5M | +18.8% | — |
| Free Cash Flow | -$11.5M | -101.1% | — |
| +0.4% |
| Stockholders' Equity | $56.6M | +0.9% | +307.1% |